标题
Drug Development in Low- and Middle-Income Countries: Opportunity or Exploitation?
作者
关键词
-
出版物
American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Volume -, Issue 42, Pages 3-10
出版商
American Society of Clinical Oncology (ASCO)
发表日期
2022-06-04
DOI
10.1200/edbk_10033
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global consequences of the US FDA's accelerated approval of cancer drugs
- (2022) Amol Akhade et al. LANCET ONCOLOGY
- Geographical Representation of Low- and Middle-Income Countries in Randomized Clinical Trials for COVID-19
- (2022) Mahesh Ramanan et al. JAMA Network Open
- An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries
- (2021) J. Connor Wells et al. JAMA Oncology
- The COVID-19 pandemic and new clinical trial activations
- (2021) Joseph M. Unger et al. Trials
- Current FDA-Approved Therapies for High-Grade Malignant Gliomas
- (2021) Jacob P. Fisher et al. Biomedicines
- Lack of equipoise in the LIGHTHOUSE trial for patients with relapsed multiple myeloma: An ethical concern
- (2021) Ghulam Rehman Mohyuddin et al. EUROPEAN JOURNAL OF CANCER
- Budget Impact Analysis of the Introduction of Rituximab and Trastuzumab Intravenous Biosimilars to EU-5 Markets
- (2020) Minyoung Jang et al. BIODRUGS
- Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers
- (2019) Rachna T. Shroff et al. JAMA Oncology
- Global Cancer Clinical Trials—Cooperation Between Investigators in High-Income Countries and Low- and Middle-Income Countries
- (2018) Pankaj Kumar Panda et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
- (2017) Ariadna Tibau et al. JNCI-Journal of the National Cancer Institute
- Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks
- (2017) Joseph C Del Paggio et al. LANCET ONCOLOGY
- Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
- (2017) Courtney Davis et al. BMJ-British Medical Journal
- Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13
- (2017) Courtney Davis et al. BMJ-British Medical Journal
- Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
- (2017) Ariadna Tibau et al. JNCI-Journal of the National Cancer Institute
- A novel nanopolymer based tumor targeted delivery system for paclitaxel
- (2017) A. T. Singh et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of regulatory assessment on clinical studies in Brazil
- (2016) Luis Augusto Tavares Russo et al. Revista da Associacao Medica Brasileira
- Cancer research in India: national priorities, global results
- (2014) Richard Sullivan et al. LANCET ONCOLOGY
- Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity
- (2014) Tito Fojo et al. JAMA Otolaryngology-Head & Neck Surgery
- The role of generic medicines and biosimilars in oncology in low-income countries
- (2013) L. Renner et al. ANNALS OF ONCOLOGY
- Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?
- (2013) John-Arne Røttingen et al. LANCET
- Cancer survival: global surveillance will stimulate health policy and improve equity
- (2013) Michel P Coleman LANCET
- Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
- (2013) Yuankai Shi et al. LANCET ONCOLOGY
- Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification
- (2013) C Heneghan et al. BMJ Open
- Expansion of cancer care and control in countries of low and middle income: a call to action
- (2010) Paul Farmer et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now